Cover Image
Market Research Report

Nanobiotechnology

Published by Global Industry Analysts, Inc. Product code 236769
Published Content info 267 Pages
Delivery time: 1-2 business days
Price
Back to Top
Nanobiotechnology
Published: January 1, 2017 Content info: 267 Pages
Description

This report analyzes the worldwide markets for Nanobiotechnology in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 79 companies including many key and niche players such as -

Ablynx NV
Arrowhead Pharmaceuticals, Inc.
Avadel Pharmaceuticals plc
CaPtivate Pharmaceuticals LLC
Celgene Corporation

Table of Contents
Product Code: MCP-1476

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations

Disclaimers

Data Interpretation & Reporting Level

  • Quantitative Techniques & Analytics

Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • A Curtain Raiser
  • Nanobiotechnology - The Next Big Thing
  • An Insight into the Global Nanobiotechnology Market
  • Major Market Drivers
  • Where Conventional Molecular Science Falls Short...Nanobio Steps In
  • Nanotechnology Revolutionizes Pharmaceuticals & Healthcare Sector
  • Nanomedicine Market to Achieve Phenomenal Growth
  • Opportunities Galore for Nanomedicine
  • Drug Delivery - A Promising Application Area for Nanotechnology
    • Benefits Offered by Nanostructures in Drug Delivery
    • Select Key Requirements for Development of Advanced Drug Delivery Systems
  • Nanotechnology Offers Huge Potential in Brain Disorder Treatment
  • High Demand for Nanobots and Nano Healthcare Devices
  • Nanotechnology Gaining Prominence for Treatment of Cancer
  • Nanotechnology in Drug Delivery: A Specialized Market Opportunity
  • Commercialization of Nanotechnology-based Medical Products Gains Momentum
  • Nanodiagnostic Products to Witness Strong Demand Growth
  • Dendrimers Serve as a Base to Build Multifunctional Nanodevices
  • Nanotechnology Rescues Poor Water Soluble Drugs from Abandonment
  • Huge Opportunities for Nanomaterials in the Medical Field
  • Commercial Opportunities in Healthcare Sector
  • Future Possibilities
  • Global Market for Fullerenes - An Insight
  • Dawn Breaks on Nanobiotechnology
  • Demystifying the Intriguing World of Nanobiotech
  • A Meeting Place of Medicine's Best Solutions
  • Nanobiotechnology to Become Viable for All Drug Development Stages
  • Nanoparticles: The Foundation of Nanobiotechnology
  • Improved Optical Properties and Stability of Nanoparticles
  • Nanoemulsions
  • The Promise of Nanobiotechnology
  • Biological Weaponries against Diseases Come in Small Packages
  • Proffered Benefits of Nanobiotechnology
  • Opportunity & Beyond
  • Nanobiotechnology - Will it Live Up to the Expectations?
  • The Future of Nanobiotechnology: Shape of Things to Come
  • Nanobiotechnology: The Outer Limits
  • Futuristics: A Rumination
  • Conclusions

2. COMPETITIVE SCENARIO

  • Competition in Select Segments
  • Nanoparticles
  • Nanotubes and Fullerenes
  • Dendrimers
  • Small and Medium-Sized Enterprises Spearheading Product Development
  • List of Select Approved Nanotechnology-based Drug Delivery Devices
  • Status of Select Nanoscale Drug Delivery Devices
  • Collaborations Activity Picking Up Pace in Nanomedicine Domain

3. MARKET DYNAMICS

  • Present Status and Future Opportunities
  • Outlook
  • Developing Countries to Rise over the Horizon
  • Nanomaterials & Nanoparticles Witness Robust Activity
  • Focus on Improved Performance to Bring New Manufacturing Methods for Nanomaterials
  • Why Invest in Nanobiotechnology?
  • Private and Public Companies to Step Up Funding on Nanotechnology
  • United States Lead the Way in Government Funding
  • Increasing Awareness on Technology to Drive Growth
  • Demand for Novel Products to Push Up Growth
  • Nano-Enabled Drug Discovery Holds Tremendous Potential
  • Consolidation Sharpens the Industry's Edge
  • The Regulatory Framework Evolves with the Technology
    • Nanobiotechnology Gathers a Miniscule Share in Biotechnology Patents
    • Table 1: Percentage Breakdown of Number of Nanotechnology Publications in USPTO & EPO by Region/Country (2016) (includes corresponding Graph/Chart)
  • Quantum Dot Patents Pose Legal Tangles
  • Miniaturized Liquid Handling Becomes Progressive
  • Trends in Nanotechnology Enabled Drug Delivery Systems
    • Robust Growth on the Cards
    • Table 2: Global Nanomedicine Market by Application (2015): Percentage Breakdown of the Market for Drug Delivery, Implants, In vivo Diagnostics and In vitro Diagnostics (includes corresponding Graph/Chart)
  • Patent Expiries: A Key Driver
  • Nanotechnology Enabled Drug Delivery to Exhume Unused Drugs

4. INDUSTRY CHALLENGES & ISSUES

  • Challenges
  • Commercial Exploration: A Treacherous Voyage
  • Conventional Medicine to Contest Nanomedicine Adoption
  • Complexity of Nanotechnology Based Diagnostics and Treatment Methods Pose Challenges
  • Nanomaterials Use: Weighed Down with Toxicity Concerns
  • Production Issues Continue to Plague Nanobiotech Industry
  • Lack of De Facto Standards: A Challenge to Reckon With
  • Embroilment over Ethical Issues
  • Social Relevance
  • Economic Relevance

5. INDUSTRY STRUCTURE

  • Industry Structure: A Quick Primer
  • A Peek into the Regulatory Framework
  • United States
  • Europe
  • A Closer Look at Regional Nano Efforts
  • United States: Unraveling the Country's Edge
    • Table 3: Nanotechnology Patents in United States Patent and Trademark Office by Leading Countries: 2014-2016 (Sep) (includes corresponding Graph/Chart)
    • Table 4: Nanotechnology Patents In European Patent Office by Leading Countries: 2014-2016 (Sep) (includes corresponding Graph/Chart)
    • Table 5: Leading Countries in Terms of Number of Research Publications for Nanopolymeric Cardiac Scaffolds: 2005-2015 (June) (includes corresponding Graph/Chart)
  • Europe: Hot on the Heels of the US
    • Germany
    • France
    • United Kingdom
    • Scandinavia
  • Japan: A Noteworthy Region

6. NANOBIO'S EPOCHAL STRIDES IN MODERN MEDICINE

  • A Primer
  • Impact on Drug Delivery Systems
  • Benefits Offered
    • Drug Encapsulation
    • High Level of Specificity
    • Increase in Drug Solubility and Uptake
    • Greater Usage Flexibility
  • Impact on Molecular Diagnostic Imaging
  • Seeing the Unseen
  • Impact on Therapeutics
  • Silver Nanoparticles as Effective Antimicrobial Agents
  • Modern Day Nanomedicine: A Current Scenario
  • Nanomedicine: The Cynosure of All Eyes
    • Applications of Nanomedicine
      • Drug Delivery
      • Drugs/ Therapy
      • In Vivo Imaging
      • In Vitro Diagnostics
      • Biomaterials
      • Active Implants
    • Drug Delivery Systems Epitomized by Nanomedicine
      • Targeted NanoDrug Delivery & Release
      • Active and Passive Targeting Mechanisms in Drug Delivery
      • Sustained and Pulsatile Release Mechanisms in Drug Delivery
      • A Peek into Potential Nanobio Enabled Drug Carriers
      • Micelles
      • Liposomes
      • Dendrimers & Liquid Crystals
      • Nanoparticles
      • Polymeric Nanoparticles
      • Hydrogels
      • Molecularly Imprinted Polymers
      • Microelectromechanical Systems (MEMS)
      • Nanosuspensions
      • Fullerenes: A Platform for GenX Drug Delivery
      • Types of Nano-Based Drug Delivery Systems, Related Materials, and Structures
      • Dynamics of Regenerative Medicine
    • Tissue Engineering and Restorations
  • Nanotechnology Enabled Diagnostics
    • Promised Path Breaking Applications in Molecular Diagnostics & Imaging
      • In-Vitro Diagnostics
      • Nanoprobes & Implantable Devices in In-vivo Imaging
      • Nanocomposites in Molecular Labeling & Diagnostics
      • Laboratory-on-a-Chip - A Revolutionary Technology in Biomolecular Detection
      • Biosensors - Heralding New Opportunities in Molecular Diagnostics
      • Nanobiosensors - A New Approach to Diagnostics Testing
      • Despite Huge Potential ... Key Hurdles Remain in Commercialization
      • Magnetic Nanoparticles for Imaging Applications in MRI
      • Dendrimers Promise Milestone Applications in MRI
  • Conclusions
  • Gauging the Real World Impact of Nanobiotech on Cancer: A Case Study
  • Quantum Dots Cock a Snook at Traditional Anti-Body Labeling Agents
  • Chemotherapeutic Reengineering & Gene Therapy: New Treatment Regimes
  • Futuristic Applications
  • Bio-molecular Motors
  • Genetic and Tissue Engineering
    • External Tissue Products
    • Internal Tissue Implants
    • Dental and Bone Replacement
    • Protein and Gene Analysis
    • Nanorobot Therapeutics
  • Laboratory-on-chip (LOC): A Portable Diagnostic Laboratory
    • Organs-On-A-Chip: Mimics Physiological Activities of Human Organs
  • Medical Diagnostic Sensors
  • Nano Medical Devices - From Surgical Tools to Contact Lenses
  • Nanoengineered Prosthetics
  • Nanotubes - Potential Drug Delivery Vehicles

7. INNOVATIONS & ADVANCEMENTS

  • A*STAR Researchers Develop Nano-Sized Drug Molecules for Cancer Treatment
  • MIT Researchers Develop Nanodevice for Fighting Against Cancer Drug Resistance
  • Gold Nanotubes for Several Applications in the Fight Against Cancer
  • IBM Research Working on NanoDLD Technology for Early Diagnosis of Cancer and other Diseases
  • Antifungal Bionanocomposites for Medical Devices
  • DNA Nanostructures for Smart Diagnosis and Drug Delivery
  • Japanese Scientists Develop CNTs with Polymeric Coatings for Enhanced Drug Delivery
  • Other Noteworthy Nanotechnology Related Technology Innovations

8. CONCEPTUAL OVERVIEW

  • Nanotechnology: An Introduction
  • A Revolution in the Making
  • Nanobiotechnology: An Exposition
  • Nanobiotechnology & Medicine
  • Nanobiotechnology & Biofuels
  • Analysis of Major Technology Segments
  • Nanomaterials
    • Nanoparticles
      • Nanoparticles in Labeling or Bio Tagging
      • Nanoparticles as Biomarkers
      • Classification of Nanoparticles
      • Solid Nanoparticles
      • Solid Lipid Nanoparticles
      • Calcium Phosphate Nanoparticles
      • Dendrimers
      • Cubosomes
    • Nanocomposites
      • Lamellar Nanocomposites
    • Nanostructured Materials and Membranes
    • Quantum Dots
    • Nanotubes and Fullerenes
      • Fullerenes
      • Nanotubes
      • Carbon Nanotubes (CNTs)
    • Other Nanomaterials
      • Nanoshells
      • Nanohorns
      • Nanocapsules
  • Nanodevices
  • Nanotools
    • Select Nanotools
      • Atomic Force Microscopes
      • Hot Embossing Lithography
      • Dip-Pen Nanolithography
  • Nanotechnology for Diseases Treatment
  • Cancer
  • Parkinson's Disease
  • Alzheimer's Disease
  • Tuberculosis
  • Dentistry
  • Ophthalmology
  • Surgery

9. GLOBAL RESEARCH CENTERS AND INSTITUTIONS

  • Cornell's Nanobiotechnology Center (USA)
  • Institute of Bioengineering and Nanotechnology (Singapore)
  • Michigan Nanotechnology Institute for Medicine and Biological Sciences (MNIMBS) (USA)
  • The Tyndall National Institute (Ireland)

10. RECENT INDUSTRY ACTIVITY

  • Vectura Group Inks Merger Agreement with Skyepharma
  • Flamel Technologies to Merge with Avadel Pharmaceuticals
  • Pfizer to Acquire BIND Therapeutics Assets
  • Janssen Sciences Ireland Enters into Collaboration with ViiV Healthcare
  • Tekna Holdings Canada Inks Agreement with National Research Council of Canada
  • Roche and BioMed X Sign a Collaboration Agreement
  • Ablynx Enters into Exclusive Research Collaboration with Genzyme
  • Pfizer Exercises Option to Develop and Commercialize Accurin
  • BIND Therapeutics Inks Joint Research and Development Agreement with Merck

11. FOCUS ON SELECT GLOBAL PLAYERS

  • Ablynx NV (Belgium)
  • Arrowhead Pharmaceuticals, Inc. (USA)
  • Avadel Pharmaceuticals plc (Ireland)
  • CaPtivate Pharmaceuticals LLC (USA)
  • Celgene Corporation (USA)
  • ELITechGroup (France)
  • GlaxoSmithKline Plc. (UK)
  • Johnson & Johnson (USA)
  • Merck & Co., Inc. (USA)
  • NanoBio(r) Corporation (USA)
  • Nanophase Technologies Corporation (USA)
  • pSivida Corp. (USA)
  • Sigma-Aldrich Corp. (USA)
  • Starpharma Holdings Ltd. (Australia)
  • Vectura Group plc (UK)

12. GLOBAL MARKET PERSPECTIVE

    • Table 6: World Recent Past, Current & Future Analysis for Nanobiotechnology by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 7: World Historic Review for Nanobiotechnology by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 8: World 14-Year Perspective for Nanobiotechnology by Geographic Region - Percentage Breakdown of Revenues for US, Japan, Europe, and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Industry Overview
    • Academic Research Lending Strength to Creation of Novel Nanobiotech Products
    • Table 9: Number of Drugs Approved by FDA: 2001-2016 (includes corresponding Graph/Chart)
    • Public Sector Funding
    • Table 10: National Nanotechnology Initiative Budget in US$ Million by Agency (2015-2017) (includes corresponding Graph/Chart)
    • Connecticut - A Key Region with Focus on Nanomedicine
    • Patent Activity in Nanomedicine Domain
    • Major Nanobiotechnology Institutions and Centers
      • The Nanobiotechnology Center (NBTC)
      • Key Technological Advances Achieved by NBTC
      • Principal NBTC Partners
      • Michigan Nanotechnology Institute for Medicine and Biological Sciences (MNIMBS)
      • Centers of Cancer Nanotechnology Excellence (CCNEs)
    • Regulatory Environment
      • FDA's Regulatory Approach to Nanotechnology Products
      • The Perils of Current Regulatory Status on Nanostructures
      • Few Challenges Faced by FDA
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 11: US Recent Past, Current & Future Analysis for Nanobiotechnology Market Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 12: US Historic Review for Nanobiotechnology Market Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

2. JAPAN

  • A. Market Analysis
    • Outlook
    • Table 13: R&D Expenditure in Japan (2015): Percentage Breakdown of Expenditure by Industrial Sector for Energy, Environmental S&T, ICTs, Life sciences, Materials, Nanotechnology, and Others (includes corresponding Graph/Chart)
    • Nanomedicines in Japan - An Overview
      • List of Select Nanomedicines Approved in Japan
      • Regulations on Nanomedicine in Japan
  • B. Market Analytics
    • Table 14: Japanese Recent Past, Current & Future Analysis for Nanobiotechnology Market Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 15: Japanese Historic Review for Nanobiotechnology Market Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

3. EUROPE

  • A. Market Analysis
    • The Rise of Nanobiotechnology in Europe
    • EU Gears Up for Clarity on Nanomedicine Regulations
    • Market Overview
      • Nano2Life Network
    • Public Sector Funding
    • Regulatory Environment
      • Registration for Novel Nanobiotech Drugs Pose Major Bottlenecks
    • A Snapshot of Nanotherapeutic Products in the EU
      • List of Select Oral Nanotherapeutic Products
      • List of Select Nanotherapeutic Products for Parenteral Administration
      • List of Select Nanotherapeutic Products for Parenteral Administration in the EU
    • Focus on Select Markets
      • Germany
      • A Regional Hub for Nanomedicine Research
      • France
      • Nanotechnology and Nanomedicine - An Overview
      • Regulations on Nanomaterials
      • United Kingdom
      • UK Bets on Advancing Nanotechnology
      • Russia
      • Russian Biotech Players Eye Partnerships with Indian Counterparts
      • Rest of Europe
      • Ireland
      • Market Overview
      • Key Research Institutions/Centers in Nanobiotechnology
      • The Tyndall National Institute
      • The Centre for Research on Adaptive Nanostructures and NanoDevices
      • The National Centre for Sensor Research
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 16: European Recent Past, Current & Future Analysis for Nanobiotechnology Market Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 17: European Historic Review for Nanobiotechnology Market Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4. REST OF WORLD

  • A. Market Analysis
    • Public Sector Funding
    • Focus on Select Markets
      • Australia
      • Market Overview
      • Major Institutions
      • Commonwealth Scientific and Industrial Research Organisation (CSIRO)
      • China
      • New Findings Reinforce Role of Silica Nanoparticles in Drug Delivery and Diagnostics
      • Nanotechnology Patent Profile in China
      • India
      • Market Overview
      • Nanotechnology to Spur Indian Pharmaceutical Industry
      • Government Takes Big Initiatives to Promote Nanobiotechnology
      • Agriculture, Livestock Sectors to Warm Up to Nanobiotechnology Benefits
      • South Korea
      • Taiwan
      • Nanotechnology in Medicine - Small Yet Growing Segment in Taiwan
      • Iran
    • Strategic Corporate Development
    • Starpharma Holdings Ltd. - A Major Australian Player
  • B. Market Analytics
    • Table 18: Rest of World Recent Past, Current & Future Analysis for Nanobiotechnology Market Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 19: Rest of World Historic Review for Nanobiotechnology Market Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Back to Top